UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 13, 2015
MedAssets, Inc.
(Exact name of registrant as specified in its charter)
| | | | |
| Delaware | | 001-33881 | | 51-0391128 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
100 North Point Center E, Suite 200, Alpharetta, Georgia | | 30022 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: 678-323-2500
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02. | Results of Operations and Financial Condition. |
(a)
On January 13, 2015, MedAssets, Inc. (the “Company”) provided preliminary commentary regarding the Company’s expected financial performance for the period ended December 31, 2014. As announced on January 2, 2015 via press release, the Company’s management team will present at the J.P. Morgan Healthcare Conference on Tuesday, January 13, 2015 at 10:30 am ET (7:30 am PT). A link to the live audio webcast and associated presentation is available in the “Events & Presentations” section of MedAssets’ investor relations website athttp://ir.medassets.com. A copy of the presentation is attached as Exhibit 99.1 and the information in the presentation as to the Company’s projected 2014 results of operations and financial condition and the safe harbor statement are hereby incorporated by reference in this Item 2.02.
Item 2.02, the information incorporated by reference herein, and Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 (the “Securities Act”) or the Exchange Act, regardless of any general incorporation language in such filing.
| Item 9.01. | Financial Statements and Exhibits. |
| | |
Exhibit
Number | | Description |
| |
| 99.1 | | Performance Improvement for Healthcare Providers, J.P. Morgan Healthcare Conference, dated January 13, 2015. |
This exhibit is furnished pursuant to Item 2.02 and shall not be deemed to be “filed.”
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | |
| | | | MedAssets, Inc. |
| | | |
| January 13, 2015 | | | | By: | | /s/ Charles O. Garner |
| | | | Name: | | Charles O. Garner |
| | | | Title: | | Executive Vice President, Chief Financial Officer |
EXHIBIT INDEX
| | |
Exhibit
No. | | Description |
| |
| 99.1 | | Performance Improvement for Healthcare Providers, J.P. Morgan Healthcare Conference, dated January 13, 2015. |
